Clonal evolution of the 3D chromatin landscape in patients with relapsed pediatric B-cell acute lymphoblastic leukemia

S Narang, Y Ghebrechristos, NA Evensen… - Nature …, 2024 - nature.com
Relapsed pediatric B-cell acute lymphoblastic leukemia (B-ALL) remains one of the leading
causes of cancer mortality in children. We performed Hi-C, ATAC-seq, and RNA-seq on 12 …

OpenPBTA: The Open Pediatric Brain Tumor Atlas

JA Shapiro, KS Gaonkar, SJ Spielman, CL Savonen… - Cell genomics, 2023 - cell.com
Pediatric brain and spinal cancers are collectively the leading disease-related cause of
death in children; thus, we urgently need curative therapeutic strategies for these tumors. To …

Proteomics study of primary and recurrent adamantinomatous craniopharyngiomas

H Deng, T Lei, S Liu, W Hao, M Hu, X Xiang, L Ye… - Clinical Proteomics, 2024 - Springer
Abstract Background Adamantinomatous craniopharyngiomas (ACPs) are rare benign
epithelial tumours with high recurrence and poor prognosis. Biological differences between …

Multi-omics analysis of adamantinomatous craniopharyngiomas reveals distinct molecular subgroups with prognostic and treatment response significance

X Wang, C Zhao, J Lin, H Liu, Q Zeng… - Chinese Medical …, 2024 - mednexus.org
Background: Adamantinomatous craniopharyngioma (ACP) is the commonest pediatric
sellar tumor. No effective drug is available and interpatient heterogeneity is prominent. This …

Diagnosis and management of children and adult craniopharyngiomas: a French Endocrine Society/French Society for Paediatric Endocrinology & Diabetes …

T Cuny, R Reynaud, G Raverot, R Coutant… - Annales d' …, 2024 - Elsevier
Craniopharyngiomas are rare hypothalamic-pituitary tumors found in young children,
adolescents and adults, and their multidisciplinary management required, calls for …

Immune infiltration in aggressive papillary craniopharyngioma: High infiltration but low action

Y Jia, L Ma, K Cai, B Zhang, W Wu, Y Xiao… - Frontiers in …, 2022 - frontiersin.org
Papillary craniopharyngiomas (PCPs) are biologically benign but clinically aggressive
lesions hence affect the quality of life. The expression of inflammatory mediators and …

[HTML][HTML] A 55-Year-Old Woman Presenting with a Second Diagnosis of Craniopharyngioma Following Diagnosis and Successful Treatment of Craniopharyngioma as …

A Alarayedh, R Sulimani, E Alsaeed… - The American Journal …, 2024 - ncbi.nlm.nih.gov
Objective: Unusual clinical course Background: Craniopharyngioma is a rare, partly cystic
embryonic malformation of the sellar and parasellar region and is usually benign. This report …

Nuove frontiere terapeutiche nel craniofaringioma

S Raia, S Chiloiro, A Giampietro, L De Marinis… - L'Endocrinologo, 2024 - Springer
Il craniofaringioma (CP) è un tumore raro della regione sellare e sovra-sellare che, sulla
base delle teorie al momento più accreditate, può originare dai residui epiteliali delle cellule …